We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

Home > News > Policy

Pennsylvania Regulator Recalls Hundreds of Cannabis Vapes

By Leo Bear-McGuinness

Published: Feb 08, 2022   

Complete the form below and we will email you a PDF version of "Pennsylvania Regulator Recalls Hundreds of Cannabis Vapes"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Analytical Cannabis?

Analytical Cannabis Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Pennsylvania Regulator Recalls Hundreds of Cannabis Vapes

Cannabis regulators in Pennsylvania have recalled hundreds of vape products because they contain ingredients “not approved for inhalation” by the US Food and Drug Administration (FDA).

On February 4, the state Department of Health issued a list of over 500 medical cannabis vape products, manufactured by 17 different companies, that must be recalled from dispensaries and medical cannabis providers.

Many of the ingredients that concern the state department are terpenes, the chemicals that are said to give cannabis varieties their flavor. Caryophyllene, humulene, myrcene and many other terpenes are listed in a PA Department of Health spreadsheet of chemicals “not approved for inhalation” by the FDA.

“Although some of these added ingredients may be considered safe in other non-inhaled products, patients safety is the top priority of the Medical Marijuana Program,” the health department wrote in a statement.

Any medical cannabis patient who has used one or more of the recalled products has been advised by the PA Department of Health to consult a medical professional at a dispensary “to help identify which alternative products may be appropriate for you.”

The recall follows a Department of Health review that was first announced on December 1 last year.

 

Like what you just read? You can find similar content on the topic tags shown below.

Policy Science & Health Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement